- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/25 - Growth hormone-releasing factor [GH-RF] (Somatoliberin)
Patent holdings for IPC class A61K 38/25
Total number of patents in this class: 194
10-year publication summary
12
|
8
|
14
|
6
|
8
|
19
|
21
|
7
|
13
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
University of Miami | 823 |
20 |
MannKind Corporation | 531 |
11 |
Theratechnologies Inc. | 57 |
10 |
The General Hospital Corporation | 4517 |
8 |
Centro de Ingenieria Genetica y Biotecnologia | 197 |
7 |
The United States Government AS represented by The Department of Veterans Affairs | 949 |
6 |
The United States of America as represented by the Department of Veterans Affairs | 310 |
6 |
Ferring B.V. | 705 |
5 |
Mondobiotech Laboratories AG | 311 |
5 |
ADViSYS, Inc. | 12 |
4 |
Xeris Pharmaceuticals, Inc. | 94 |
4 |
Oxeia Biopharmaceuticals, Inc. | 14 |
4 |
Alize Pharma SAS | 4 |
3 |
Daiichi Sankyo Company, Limited | 1829 |
3 |
Ipsen Pharma S.A.S. | 402 |
3 |
OCERA Therapeutics, Inc. | 59 |
3 |
Edix SA | 10 |
3 |
Hexamer Therapeutics Inc. | 9 |
3 |
The Regents of the University of California | 18943 |
2 |
The Administrators of the Tulane Educational Fund | 368 |
2 |
Other owners | 82 |